Switch to:
More From Other Websites
Shire's NDA Resubmission for Lifitegrast Accepted by FDA Feb 05 2016
Momentum, Strategy within Today's Market - Analyst Notes on AmerisourceBergen, Xcel Energy, Shire... Feb 05 2016
3:48 pm Shire plc: FDA acknowledges receipt of the resubmitted NDA for lifitegrast for the treatment... Feb 04 2016
U.S. FDA Acknowledges Receipt of Resubmission of Shire's New Drug Application for Lifitegrast for... Feb 04 2016
Drug Manufacturers - Major Equities Technical Updates -- TherapeuticsMD, Sanofi, Shire, and Novartis Feb 04 2016
Will AmerisourceBergen's (ABC) Q1 Earnings Disappoint? Feb 03 2016
SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits Feb 03 2016
Headline Risk Is Poison for Pharma and Biotech Feb 03 2016
SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits Feb 01 2016
Total Voting Rights Feb 01 2016
AbbVie cuts costs, turns profit that meets 4Q expectations Jan 29 2016
SHIRE PLC Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and... Jan 28 2016
Pharma firm gets FDA approval for ADHD drug, more jobs likely Jan 28 2016
Shire PLC assigned investment grade ... Jan 28 2016
Shire plc Assigned Investment Grade Credit Ratings by Moody's and S&P Jan 28 2016
Shire to announce Full Year 2015 ... Jan 28 2016
Shire plc -- Moody's assigns Baa3 issuer rating to Shire plc; stable outlook Jan 28 2016
The Baxalta–Shire merger: Basics of Shire Pharmaceuticals Jan 26 2016
Shire stays mum on Burlington facilities, employees in wake of Dyax acquisition Jan 25 2016
Shire Resubmits New Drug Application ... Jan 25 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK